Skip to main content
Subscribe
Register
Sign in
Membership
Events
Knowledge Center
About
Subscribe
Register
Sign in
Premium
Alternative Insight and Premium Journalism
Latest Articles
Premium
Haidar Surged 27% in June
Stephen Taub
July 10, 2023
Premium
Suvretta’s Prescription for Growth
Stephen Taub
July 6, 2023
Premium
Hedge Fund Favorites Continue to Beat the Market
Stephen Taub
July 5, 2023
Premium
Greenlight Surges in June
Stephen Taub
July 3, 2023
Premium
At Hedge Funds, Private Market Investments Continue to Languish
Stephen Taub
June 29, 2023
Premium
Hedge Funds Miss the Boat
Stephen Taub
June 28, 2023
Premium
Hedge Funds Eye Biopharma IPO
Stephen Taub
June 27, 2023
Premium
Sosin Partners Goes Activist
Stephen Taub
June 26, 2023
Premium
Biopharma M&A Finally Seems To Be Waking Up
Stephen Taub
June 22, 2023
Premium
For Viking, Slow and Steady Wins the Race
Stephen Taub
June 21, 2023
Premium
Gabe Plotkin’s Next Act
Stephen Taub
June 20, 2023
Premium
SEC Charges Hedge Fund for Repeat Offense
Stephen Taub
June 15, 2023
Premium
Biopharma Funds Rebound in May
Stephen Taub
June 14, 2023
Premium
Tiger Funds Take Steps Toward Recovery
Stephen Taub
June 13, 2023
Premium
Carvana Helps Sosin Rebound
Stephen Taub
June 12, 2023
Premium
Another Ho-Hum Month for Haidar
Stephen Taub
June 8, 2023
Premium
Jericho Looks to Extend Rebound
Stephen Taub
June 7, 2023
Premium
Third Point Takes a Large Amazon Stake
Stephen Taub
June 6, 2023
More Articles